Glaxo unlocking hidden value

Growth coupled with currency tailwind proves a heady mix
Thursday 01 Dec 2016 Author: William Cain
Large and complex conglomerates are often packed with hidden value which can ultimately be unlocked to the benefit of investors. National champion pharmaceuticals outfit GlaxoSmithKline ( GSK ) is perhaps the most obvious example on the London market. The great news for investors is the business is already well underway to creating what is potentially a mind-blowing amount of value. On top of that, a currency tailwind helped Glaxo’s...

Important information:

These articles are provided by Shares magazine which is published by AJ Bell Media, a part of AJ Bell. Shares is not written by AJ Bell Youinvest.

Shares is provided for your general information and use and is not a personal recommendation to invest. It is not intended to be relied upon by you in making or not making any investment decisions. The investments referred to in these articles will not be suitable for all investors. If in doubt please seek appropriate independent financial advice.

Investors acting on the information in these articles do so at their own risk and AJ Bell Media and its staff do not accept liability for losses suffered by investors as a result of their investment decisions.

The Shares team
Disclaimer

The value of your investments can go down as well as up and you may get back less than you originally invested. We don't offer advice, so it's important you understand the risks, if you're unsure please consult a suitably qualified financial adviser. Tax treatment depends on your individual circumstances and rules may change. Past performance is not a guide to future performance and some investments need to be held for the long term.